Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | AMGN | VRTX | REGN | GSK |
| Company | Intra-Cellular Ther | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 67.66 | 297.61 | 477.73 | 1,024.30 | 40.82 |
| High | 69.28 | 299.74 | 483.53 | 1,042.66 | 40.88 |
| Low | 66.57 | 295.90 | 477.73 | 1,017.96 | 40.48 |
| Last | 67.77 | 298.62 | 480.73 | 1,036.52 | 40.65 |
| Change | -0.64 | +0.12 | +1.70 | +9.97 | -0.46 |
| % Change | -0.94% | +0.04% | +0.35% | +0.97% | -1.12% |
| Volume | 636,000 | 1,713,600 | 641,700 | 353,900 | 2,235,300 |
| 20-Day Average Volume | 704,930 | 2,175,800 | 1,196,295 | 382,520 | 3,991,900 |
| Previous Close | 68.41 | 298.50 | 479.03 | 1,026.55 | 41.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 67.26 | 305.18 | 463.59 | 994.90 | 42.98 |
| 20-Day Raw Stochastic | 58.04% | 15.54% | 88.80% | 93.20% | 3.29% |
| 20-Day Relative Strength | 49.10% | 49.90% | 69.81% | 69.37% | 39.17% |
| Weighted Alpha | +8.66 | +26.02 | +43.64 | +35.89 | +13.64 |
| Today's Opinion | 24% Buy | 88% Buy | 100% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 24% Buy | 88% Buy | 100% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 24% Buy | 72% Buy | 56% Buy | 72% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.94% since 06/07/24 | -2.10% since 06/07/24 | -0.48% since 06/07/24 | +3.35% since 06/07/24 | -1.36% since 06/07/24 |
| Low | 66.57 on 06/14/24 | 295.30 on 06/13/24 | 472.61 on 06/13/24 | 992.22 on 06/10/24 | 40.47 on 06/14/24 |
| High | 70.43 on 06/12/24 | 305.53 on 06/10/24 | 485.40 on 06/10/24 | 1,042.66 on 06/14/24 | 41.51 on 06/10/24 |
| 1-Month | |||||
| %Chg | +3.13% since 05/14/24 | -4.11% since 05/14/24 | +12.17% since 05/14/24 | +5.27% since 05/14/24 | -10.97% since 05/14/24 |
| Low | 64.09 on 05/20/24 | 295.30 on 06/13/24 | 428.62 on 05/15/24 | 952.30 on 05/30/24 | 40.47 on 06/14/24 |
| High | 70.43 on 06/12/24 | 321.44 on 05/15/24 | 486.42 on 06/07/24 | 1,042.66 on 06/14/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | +4.96% since 03/14/24 | +9.97% since 03/14/24 | +17.60% since 03/14/24 | +8.08% since 03/14/24 | -5.64% since 03/14/24 |
| Low | 63.87 on 03/19/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 84.89 on 04/16/24 | 322.60 on 05/03/24 | 486.42 on 06/07/24 | 1,042.66 on 06/14/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +3.75% since 12/14/23 | +8.07% since 12/14/23 | +18.23% since 12/14/23 | +18.32% since 12/14/23 | +9.92% since 12/14/23 |
| Low | 62.78 on 02/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 838.46 on 12/21/23 | 35.87 on 12/15/23 |
| High | 84.89 on 04/16/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,042.66 on 06/14/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,154,817 | 160,190,224 | 124,053,832 | 114,209,984 | 84,244,688 |
| Shares Outstanding, K | 105,575 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 464,370,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -139,670,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 144,870,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -15,250,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 0.97 | 0.60 | 0.41 | 0.13 | 0.66 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 05/07/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 08/01/24 | 08/01/24 | 08/06/24 | 08/01/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.02 | 31.81 | 27.66 | 10.18 |